Globus Medical (GMED) Long-Term Deferred Tax (2011 - 2026)

Globus Medical (GMED) has 15 years of Long-Term Deferred Tax data on file, last reported at $214.8 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 84.13% year-over-year to $214.8 million; the trailing twelve-month figure through Mar 2026 stood at $214.8 million (up 84.13% YoY), and the FY2025 full-year result was $218.2 million, up 131.65% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $214.8 million, down from $218.2 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $275.9 million in Q2 2025 and bottomed at $7.3 million in Q3 2023.
• The 5-year median for Long-Term Deferred Tax is $48.8 million (2022), against an average of $89.2 million.
• The widest annual swing landed in 2023, when Long-Term Deferred Tax plunged 83.64%; it then jumped 1416.0% in 2025.
• A 5-year view of Long-Term Deferred Tax shows it stood at $48.8 million in 2022, then slumped by 78.12% to $10.7 million in 2023, then jumped by 781.61% to $94.2 million in 2024, then surged by 131.65% to $218.2 million in 2025, then dropped by 1.56% to $214.8 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $214.8 million (Q1 2026), $218.2 million (Q4 2025), and $232.4 million (Q3 2025), per Business Quant data.

Peer Comparison